Seroatlas · Human Serome Atlas

GATM

Glycine amidinotransferase, mitochondrial

Also known as: AGAT, GATM_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P50440
Gene
GATM
Ensembl
ENSG00000171766
Chromosome
15
Canonical length
423 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Mitochondria
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes a mitochondrial enzyme that belongs to the amidinotransferase family. This enzyme is involved in creatine biosynthesis, whereby it catalyzes the transfer of a guanido group from L-arginine to glycine, resulting in guanidinoacetic acid, the immediate precursor of creatine. Mutations in this gene cause arginine:glycine amidinotransferase deficiency, an inborn error of creatine synthesis characterized by cognitive disability, language impairment, and behavioral disorders. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

423 residues, UniProt reviewed canonical sequence.

>P50440|GATM
     1  MLRVRCLRGG SRGAEAVHYI GSRLGRTLTG WVQRTFQSTQ AATASSRNSC AADDKATEPL
    61  PKDCPVSSYN EWDPLEEVIV GRAENACVPP FTIEVKANTY EKYWPFYQKQ GGHYFPKDHL
   121  KKAVAEIEEM CNILKTEGVT VRRPDPIDWS LKYKTPDFES TGLYSAMPRD ILIVVGNEII
   181  EAPMAWRSRF FEYRAYRSII KDYFHRGAKW TTAPKPTMAD ELYNQDYPIH SVEDRHKLAA
   241  QGKFVTTEFE PCFDAADFIR AGRDIFAQRS QVTNYLGIEW MRRHLAPDYR VHIISFKDPN
   301  PMHIDATFNI IGPGIVLSNP DRPCHQIDLF KKAGWTIITP PTPIIPDDHP LWMSSKWLSM
   361  NVLMLDEKRV MVDANEVPIQ KMFEKLGITT IKVNIRNANS LGGGFHCWTC DVRRRGTLQS
   421  YLD

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GATM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
2,768 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 2,768 nTPM
  • liver: 2,621 nTPM
  • kidney: 1,960 nTPM
  • spinal cord: 208 nTPM
  • duodenum: 165 nTPM
  • amygdala: 142 nTPM

Single-cell type

  • hepatocytes: 1,860 nCPM
  • pancreatic acinar cells: 1,025 nCPM
  • granulosa cells: 630 nCPM
  • gastric chief cells: 222 nCPM
  • cholangiocytes: 218 nCPM
  • epididymal efferent duct absorptive cells: 193 nCPM

Immune cell

  • memory B-cell: 11 nTPM
  • plasmacytoid DC: 6.8 nTPM
  • myeloid DC: 6.6 nTPM
  • naive B-cell: 5.4 nTPM
  • intermediate monocyte: 1.6 nTPM
  • naive CD8 T-cell: 1.4 nTPM

Brain region

  • white matter: 200 nTPM
  • medulla oblongata: 147 nTPM
  • cerebellum: 146 nTPM
  • spinal cord: 138 nTPM
  • pons: 137 nTPM
  • hypothalamus: 123 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GATM.

Disease | AllUniProt

Conditions GATM is implicated in, by any mechanism.

Disease | GeneticClinVar

38 pathogenic / likely-pathogenic of 668 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.53
gnomAD pLI
0.05
gnomAD missense Z
2.29
DepMap mean gene effect
0
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

  • amidinotransferase activity
  • glycine amidinotransferase activity

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • Glycine/inosamine-phosphate amidinotransferase-like

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GATM as an antibody target. Whether an autoantibody or antibody against GATM could matter depends on whether native GATM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GATM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GATM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GATM. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...